{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "New York",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90064",
      "recalling_firm": "Pfizer Inc.",
      "address_1": "235 East 42nd Street",
      "address_2": "N/A",
      "postal_code": "10017-5703",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-0874-2022",
      "product_description": "Accupril (Quinapril HCl Tablets) 40 mg,  90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017",
      "product_quantity": "8346 bottles",
      "reason_for_recall": "CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.",
      "recall_initiation_date": "20220422",
      "center_classification_date": "20220516",
      "termination_date": "20231005",
      "report_date": "20220525",
      "code_info": "Lots: DX6031 Exp. MAR 31 2023; CK6260 Exp. MAY 31 2022",
      "more_code_info": ""
    }
  ]
}